대한결핵및호흡기학회 KATRDKATRDIC 2021

GNB 메뉴 보기

KATRD 2021 International Conference
November 7(Thu)-8(Fri), 2020 Lotte Hotel World, Seoul, Kore
Program

Program

Program in Detail

Oral Presentation 10
COPD 2
10:30-12:00
Pearl
Chair Jeong Woong Park (Gachon University, Korea)
10:30-10:40 OP 10-1 Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA Versus ICS/LABA in COPD Management: Findings from the Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea (CITRUS) Study
YeJin Lee (Seoul National University, Korea )
10:40-10:50 OP 10-2 Assessment of Satisfaction with the Inhaler and Determinants of High Satisfaction in COPD Patients
June Hong Ahn (Yeungnam University, Korea)
10:50-11:00 OP 10-3 Comparison of Pneumonia Incidence between LAMA and ICS/LABA in Patients with COPD : A Retrospective Cohort Study in a Real-world Setting
Eung Gu Lee (The Catholic University of Korea, Korea)
11:00-11:10 OP 10-4 Comparison of Risk of Pneumonia Caused by Fluticasone Versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
Ji-Ho Lee (Yonsei University Wonju, Korea)
11:10-11:20 OP 10-5 Association between Inhaled Corticosteroids Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease
Yong Suk Jo (Hallym University, Korea)
11:20-11:30 OP 10-6 Seasonal Variations in PM2.5 Concentrations and Clinical Impact on Chronic Obstructive Lung Disease Patients
Jin-Young Huh (University of Ulsan, Korea)
11:30-11:40 OP 10-7 Clinical Implication in COPD Assessment Test Score Changes among Newly Diagnosed COPD Patients Treated with Bronchodilators
Bo-Guen Kim (Sungkyunkwan University, Korea)
11:40-11:50 OP 10-8 Diaphragm Ultrasound is an Image Biomarker of AECOPD
Tai Joon An (The Catholic University of Korea, Korea)
11:50-12:00 OP 10-9 Systemic Antibiotics Can Deteriorate Emphysema Associated with Exaggerated Inflammation and Autophagy
Nahyun Kim (University of Ulsan, Korea)
Oral Presentation 11
Asthma
13:30-14:50
Pearl
Chair Sang-Heon Kim (Hanyang University, Korea)
13:30-13:40 OP 11-1 Dupilumab Efficacy in Patients with GINA-Defined Type 2 Asthma: Traverse
William W. Busse (University of Wisconsin School of Medicine and Public Health, USA)
13:40-13:50 OP 11-2 Prevalence of Asthma-COPD Overlap in COPD and Severe Asthma Cohorts
Hyonsoo Joo (The Catholic University of Korea, Korea)
13:50-14:00 OP 11-3 Comparative Efficacy and Safety Between Budesonide-formoterol and Fluticasone-salmeterol Combination Inhalers for Asthma Management: Retrospective Analysis from the Common Data Model
Seong-Dae Woo (Chungnam National University, Korea)
14:00-14:10 OP 11-4 Clinical Characteristics of Korean Severe Asthma Patients
Joon Young Choi (The Catholic University of Korea, Korea)
14:10-14:20 OP 11-5 Rootletin is a Marker for Asthma Exacerbation in Patients with Asthma: Implication for Diesel Exhaust Particles
seon-muk choi (Soonchunhyang University, Korea)
14:20-14:30 OP 11-6 The Prevalence of and Factors Associated with Influenza Vaccination in Patients with Asthma in Korea
Sang Hyuk Kim (Sungkyunkwan University, Korea)
14:30-14:40 OP 11-7 Cardiovascular and Cerebrovascular Mortality in Asthma Patients with Preceding Exacerbation
Soojoung Yu (Yonsei University, Korea)
14:40-14:50 OP 11-8 Pharmacovigilance Studies of Oral Salbutamol in Chronic Asthmatic Patients in Different Clinical Setups of Hyderabad, Sindh, Pakistan
Mudassar Iqbal Arain (University of Sindh, Pakistan)
Oral Presentation 12
Bronchoscopy/ Diagnostics
15:30-17:00
Pearl
Chair Chul Ho Oak (Kosin University, Korea)
15:30-15:40 OP 12-1 Diagnostic Utility of Adding Needle Aspiration (Using PeriView FLEX needle®) to Radial EBUS Transbronchial Lung Biopsy
Taehoon Lee (Ulsan University, Korea)
15:40-15:50 OP 12-2 Utility and Safety of Sole Electromagnetic Navigation Bronchoscopy Under Moderate Sedation for Lung Cancer Diagnosis
Yeon Wook Kim (Seoul National University Bundang Hospital, Korea)
15:50-16:00 OP 12-3 Is Bronchial Washing Cytology Helpful for the Diagnosis of Lung Cancer?
Sun Young Park (Ulsan University, Korea)
16:00-16:10 OP 12-4 Additional Value of Metagenomic Sequencing in Diagnosis of Ventilator-associated Pneumonia
Ha Won Hwang (Seoul National University, Korea)
16:10-16:20 OP 12-5 Efficacy of Hand-held Portable Ultrasound in Early Detection of Pneumothorax after Lung Biopsy
Manbong Heo (Seoul National University Bundang Hospital, Korea)
16:20-16:30 OP 12-6 Deep Learning-based Classification of Respiratory Sounds and Its Clinical Value
Yoonjoo Kim (Chungnam National University, Korea)
16:30-16:40 OP 12-7 Proposal of a Novel Lung Fibrosis Scoring System for Post-COVID-19 Lung Fibrosis Patients
Seo Hee Yang (Seoul National University Bundang Hospital, Korea)
16:40-16:50 OP 12-8 Mutations in gyrA and gyrB among Drug Resistant Mycobacterium Tuberculosis in Korea
Hee Joo Lee (Korean National Tuberculosis Association, Korea)
16:50-17:00 OP 12-9 Ultrathin Bronchoscope for the Diagnosis of Peripheral Pulmonary Lesions: A Systematic Review and Meta-analysis
Soo Han Kim (Pusan National University, Korea)
Oral Presentation 13
ILD 1
10:30-12:00
Ruby
Chair Sun Mi Choi (Seoul National University, Korea)
10:30-10:40 OP 13-1 Clinical Outcomes of Dose Modification During Pirfenidone Treatment in Patients with IPF
Jieun Kang (Inje University, Korea)
10:40-10:50 OP 13-2 The Efficacy of Pirfenidone in Combined Pulmonary Fibrosis and Emphysema (CPFE)
Hye Ran Gwon (Yonsei University, Korea)
10:50-11:00 OP 13-3 Prevalence of and Risk Factors for Pulmonary Complications after Curative Resection in Idiopathic Pulmonary Fibrosis Patients with Early Stage Lung Cancer
Yunjoo Im (Sungkyunkwan University, Korea)
11:00-11:10 OP 13-4 Validity of Pulmonary Artery to Aorta Ratio as a Predictor of Acute Exacerbation in Advanced Idiopathic Pulmonary Fibrosis Patients
Eun Young Kim (Yonsei University, Korea)
11:10-11:20 OP 13-5 Serum Apolipoprotein A-I Predicts the Mortality in Patients with Idiopathic Pulmonary Fibrosis
Ganghee Chae (University of Ulsan, Korea)
11:20-11:30 OP 13-6 Body Mass Index and Clinical Outcomes in Patients with Idiopathic Pulmonary Fibrosis: A Nationwide Cohort Study
Joon Han Kim (Seoul National University Bundang Hospital, Korea)
11:30-11:40 OP 13-7 The Analysis of the Effect of Ischemic Heart Disease on the Clinical Course of IPF
Seung Hoon Kim (The Catholic University of Korea, Korea)
11:40-11:50 OP 13-8 Non-tuberculous Mycobacterial Pulmonary Disease Increased the Risk of Hospitalization in Patients with Idiopathic Pulmonary Fibrosis
Jin-Young Huh (University of Ulsan, Korea)
11:50-12:00 OP 13-9 Comparison of the Clinical Course of Patients with Idiopathic Pulmonary Fibrosis According to Their Smoking Status
Kwang Yong Choi (Seoul National University, Korea)
Oral Presentation 14
ILD 2
13:30-15:00
Ruby
Chair Song Yee Kim (Yonsei University, Korea)
13:30-13:40 OP 14-1 Clinical Characteristics of Familial Idiopathic Pulmonary Fibrosis Patients in Korea
Sol Kim (Yonsei University, Korea)
13:40-13:50 OP 14-2 Clinical Features between Cryptogenic and Secondary Organizing Pneumonia in a Single Hospital
Eun Jin Kim (Daegu Catholic University, Korea)
13:50-14:00 OP 14-3 Clinical Factors Associated with Lung Function Decline and Mortality in Rheumatoid Arthritis-related Interstitial Lung Disease
Kangjoon Kim (Yonsei University, Korea)
14:00-14:10 OP 14-4 Characteristics, Mortality, and Risk Factors in Patients with Systemic Sclerosis Associated Interstitial Lung Disease
Hye Jin Jang (Yonsei University, Korea)
14:10-14:20 OP 14-5 Interstitial Lung Abnormality in Health Screening Examinees: Prevalence and Progression Rate
Jooae Choe (University of Ulsan, Korea)
14:20-14:30 OP 14-6 Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases by Composite Physiologic Index
Jin Woo Song (University of Ulsan, Korea)
14:30-14:40 OP 14-7 Diagnostic Performance of Digital Lung Auscultation for Interstitial Lung Diseases
Hanal Lee (Seoul National University Bundang Hospital, Korea)
14:40-14:50 OP 14-8 Imaging Signatures in Idiopathic Pulmonary Fibrosis (IS-IPF) Study from Multi-center Multidisciplinary Experiences in Interstitial Lung Disease
Ju Hyun Oh (University of Ulsan, Korea)
14:50-15:00 OP 14-9 Interstitial Lung Abnormality Evaluated by Automated Quantification System: Prevalence and Progression Rate
Ju Hyun Oh (University of Ulsan, Korea)
Oral Presentation 15
ILD 3
15:30-17:00
Ruby
Chair Jin Woo Kim (The Catholic University of Korea, Korea)
15:30-15:40 OP 15-1 Blood KL-6 Predicts Disease Progression in IPF Patients Receiving Antifibrotic Therapy
Myeong Geun Choi (University of Ulsan, Korea)
15:40-15:50 OP 15-2 Serum Krebs von den Lungen-6 (KL-6) as a Biomarker for the Disease Progression of Idiopathic Pulmonary Fibrosis
Chiwook Chung (University of Ulsan, Korea)
15:50-16:00 OP 15-3 Diagnostic Value of Serum Vascular Endothelial Growth Factor-D in Korean Patients with Lymphangioleiomyomatosis
Hee-Young Yoon (Seoul North Medical Hospital, Korea)
16:00-16:10 OP 15-4 Serum Proteomic Profiling of Rapid Disease Progression in Idiopathic Pulmonary Fibrosis
Kyung Hoon Chung (Seoul National University Bundang Hospital, Korea)
16:10-16:20 OP 15-5 New Biomarker in Rapid Progressor of Idiopathic Pulmonary Fibrosis
Hye Ju Yeo (Pusan National University Yangsan Hospital, Korea)
16:20-16:30 OP 15-6 Plasma Mitochondrial DNA as a Biomarker of Clinical Outcomes in Rheumatoid Arthritis-associated Interstitial Lung Disease
Jong Sun Park (Seoul National University, Korea)
16:30-16:40 OP 15-7 Exogenous Tryptophan Aggravates Experimental Lung Fibrosis Through Activation of AKT-mTORC1 Pathway
Sung Woo Park (Soon Chun Hyang University, Korea)
16:40-16:50 OP 15-8 Arachidonic Acid 12-lipoxygenase (ALOX12) Promotes Pulmonary Fibrosis
Gi Won Hwang (University of Ulsan, Korea)
16:50-17:00 OP 15-9 Periostin is a Novel Biomarker for Chronic Lung Allograft Dysfunction after Lung Transplant
Hye Ju Yeo (Pusan National University Yangsan Hospital, Korea)
Oral Presentation 16
Lung Cancer 1
10:30-12:00
Jade
Chair Ji Woong Son (Konyang University, Korea)
10:30-10:40 OP 16-1 microRNA-26a-5p Regulates the Cancer stemness and Enhances the Chemosensitivity of Lung Adenocarcinoma
Minhyeok Lee (Konyang University, Korea)
10:40-10:50 OP 16-2 Heterogeneous Radiological Response to Chemotherapy is Associated with Poor Prognosis in Advanced Non-small-cell Lung Cancer
Woo Kyung Ryu (Inha University, Korea)
10:50-11:00 OP 16-3 Clinical Significance of Advanced Lung Cancer Inflammation Index in Limited Disease Small Cell Lung Cancer Patients Treated with Chemoradiotherapy
DONG WON PARK (Hanyang University, Korea)
11:00-11:10 OP 16-4 Impaired Lung Function and Lung Cancer Incidence: A Nationwide Population-based Cohort Study
Hye Seon Kang (The Catholic University of Korea, Korea)
11:10-11:20 OP 16-5 Blood-based Biomarker Analysis for Predicting Efficacy of Definitive Concurrent Chemoradiotherapy and Durvalumab Consolidation in Patients with Unresectable Locally Advanced Non-small Cell Lung Cancer
Cheol-Kyu Park (Chonnam National University, Korea)
11:20-11:30 OP 16-6 Clinical Usefulness of Serum KL-6 Test for Predicting Occurrence and Assessing Severity of Treatment-related Interstitial Lung Disease in Lung Cancer: A Single Center Cohort Study
Hwa Kyung Park (Chonnam National University, Korea)
11:30-11:40 OP 16-7 Association between Clinical Parameters and Resectability in Stage III Non-small Cell Lung Cancer
Seohyun Kim (The Catholic University of Korea, Korea)
11:40-11:50 OP 16-8 Tri-iodothyronine (T3) as a Prognostic Factor for Patients with Advanced Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors
Yoonjoo Kim (Chungnam National University, Korea)
11:50-12:00 OP 16-9 Digital Aging and Mental Health Deteriorations: Risk Mitigation in the Older People with Lung Cancer Disease in Indonesia
Lintong Hottua Simbolon (Alumnus University of Lampung, Indonesia)
Oral Presentation 17
Lung Cancer 2
13:30-15:00
Jade
Chair Hak Ryul Kim (Wonkwang University, Korea)
13:30-13:40 OP 17-1 High Tumor Mutation Burden Predicts Unfavorable Clinical Outcomes in EGFR-mutated Lung Adenocarcinoma Treated with Targeted Therapy
Seung Hyeun Lee (Kyung Hee University, Korea)
13:40-13:50 OP 17-2 GDF-15 Levels Predict Efficacy in Lung Cancer Patients Treated with PD-1/PD-L1 Inhibitors
Da Hyun Kang (Chungnam National University, Korea)
13:50-14:00 OP 17-3 Differences in Detection Patterns, Characteristics, and Outcomes of Central and Peripheral Lung Cancers in Low-dose CT Screening
Yeon Wook Kim (Seoul National University Bundang Hospital, Korea)
14:00-14:10 OP 17-4 Comparison of Clinical Characteristics and Prognosis of Incidentally Detected and Screening Detected Lung Cancers
Sungmin Zo (Sungkyunkwan University, Korea)
14:10-14:20 OP 17-5 Incidence and Risk Factors for Brain Metastasis in Patients with Presumed Early-stage Lung Cancer
Kangjoon Kim (Yonsei University, Korea)
14:20-14:30 OP 17-6 Association Between Quality of Life Questionnaire at Diagnosis and Survival in Patients with Lung Cancer
Yu Jin Hong (The Catholic University of Korea, Korea)
14:30-14:40 OP 17-7 Clinical Factors Associated with Circulating Tumor DNA Detection in Chronic Obstructive Pulmonary Disease Patients with Lung Cancer
Sun Hye Shin (Sungkyunkwan University, Korea)
14:40-14:50 OP 17-8 Semi-supervised Deep Learning Extraction for Information of Lung Cancer Staging from Unstructured Reports of PET-CT Interpretation
Hyungjun Park (University of Ulsan, Korea)
14:50-15:00 OP 17-9 Machine Learning Classification of Bronchogenic Carcinoma based on Fuzzy Logic
Rifaldy Fajar (Yogyakarta State University, Indonesia)
Oral Presentation 18
Lung Cancer 3
15:30-17:00
Jade
Chair Hyunkyung Lee (Inje University, Korea)
15:30-15:40 OP 18-1 Effects of Developed Chronic Pulmonary Aspergillosis after Lung Cancer Surgery on Mortality and Lung Function Decline
Bo-Guen Kim (Sungkyunkwan University, Korea)
15:40-15:50 OP 18-2 Efficacy of Local Radiotherapy or Metastasectomy in Stage IV NSCLC with Single Extrathoracic Metastasis: Evaluation of Nationwide Korean Lung Cancer Populations
Jeong Uk Lim (The Catholic University of Korea, Korea)
15:50-16:00 OP 18-3 Predictability of Prior Radiotherapy and Immunotherapy-related Adverse Effects for Outcomes in Advanced NSCLC Patients Receiving Anti-PD-1/L1 Therapy
Jeong Uk Lim (The Catholic University of Korea, Korea)
16:00-16:10 OP 18-4 The Role of 6-minute Walk Test and Cardiopulmonary Exercise Test in Early-stage Lung Cancer Patients with Reduced Pulmonary Function
Daegeun Lee (Sungkyunkwan University, Korea)
16:10-16:20 OP 18-5 Association of Diagnostic Lung Biopsy on the Risk of Spread Through Air Spaces (STAS) and Its Prognostic Impact in Resected Stage I Non-Small Cell Lung Cancer (NSCLC)
Ga Young Lee (Seoul National University Bundang Hospital, Korea)
16:20-16:30 OP 18-6 Comparison of Clinical Stage and Pathologic Stage in Patients with Non-small Cell Lung Cancer
Hye Ran Gwon (Yonsei University, Korea)
16:30-16:40 OP 18-7 Real-world Experience on the Use of Durvalumab after Concurrent Chemoradiotherapy in Stage III Non-small Cell Lung Cancer
Eun Hye Lee (Yonsei University, Korea)
16:40-16:50 OP 18-8 A Propensity-matched Real-world Data Analysis of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer
Cheol-Kyu Park (Chonnam National University, Korea)
16:50-17:00 OP 18-9 Stereotactic Body Radiation Therapy in Stage I Non-small Cell Lung Cancer Patients with Peripheral Tumors in Vietnam
Luan Pham (108 Military Central Hospital, Vietnam)

Go Top

© The Korean Academy of Tuberculosis and Respiratory Diseases

Contact Secretariat of KATRDIC 2021
P&M  MS Bldg. 12, Eonju-ro 79-gil, Gangnam-gu, Seoul 06222, Korea